ρπγερθθιο ® 10 ξ"β LAR ®
|
ων δϊψετδ αΰπβμιϊ: Sandostatin ® Lar ® 10 Mg.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
INTRAGLUTEALLY
ξιπεο
Microspheres For Susp.for Inj.
ωιξεω αϊψετδ
Treatment of acromegaly in: Patients already adequately controlled on standard doses of Sandostatin s.c. Patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. Endocrine gastro-entero- pancreatic (GEP) tumors, carcinoid tumors.
ξρτψ ψιωεν
112 50 29488 00
ιφψο
Novartis Pharma Stein Ag, Switzerland
ϊεχσ ψιωιεο μϊψετδ
09/2013 - 09/2023
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
Octreotide |
10 MG |
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
Vial glass type i |
1 x VIAL |
ηεγωιν 36 |
λο |
|
|
|